Study Design (S3BA3001/S3BA3002)
2 weeks
4 weeks
12 weeks
Treatment (BID)Placebo
Alosetron 1 mg
Screening
Follow-up
(No treatment)
Diarrhea-predominant
Alternating bowel pattern
Female Only
Previous slide
Next slide
Back to first slide
View graphic version